Package 50090-5850-1

{"route": ["ORAL"], "spl_id": "f10b029f-722e-4c7e-93ea-c21e8c05c0f3", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198428"], "spl_set_id": ["5a9575bb-230e-46ae-b58e-41554bad45eb"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-5850-0)", "package_ndc": "50090-5850-0", "marketing_start_date": "20211108"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-5850-1)", "package_ndc": "50090-5850-1", "marketing_start_date": "20211108"}], "brand_name": "Lamotrigine", "product_id": "50090-5850_f10b029f-722e-4c7e-93ea-c21e8c05c0f3", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-5850", "generic_name": "Lamotrigine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "150 mg/1"}], "application_number": "ANDA077633", "marketing_category": "ANDA", "marketing_start_date": "20090127", "listing_expiration_date": "20261231"}